The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday.

The USDA says the precooked pasta products, sold at Trader Joe's and Walmart, could be connected to a nationwide listeria outbreak that has killed four people and sickened at least 20 others.

WASHINGTON—President Trump unveiled plans Tuesday to launch a government-run website, dubbed TrumpRx, for consumers to buy drugs directly from manufacturers, and he said Pfizer plans to offer some of ...

Employee furloughs and potential layoffs would halt some government activities, but other functions — like NASA's space missions, Trump's immigration crackdown and certain public health work at FDA ...

A medication made from marijuana successfully reduced back pain in a new study. The results from a German drugmaker published Monday are the latest evidence that cannabis can be used to treat common ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...

Commercial raw cat food, particularly products sold on shelves at room temperature, may pose a considerable health risk to cats and the families who care for them, according to an analysis of the ...

The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the Swiss drugmaker said on Tuesday. The twice-daily pill, ...

Drug firm Wockhardt on Wednesday said it has submitted a new drug application for its novel antibacterial drug with the US health regulator.

The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday.

The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.

President Trump’s strategy to lower prescription drug prices will be put to the test as drugmakers must now commit to the terms of his “Most Favored Nation” pricing plan or face ...